MedTrace Logo

Safety and Efficacy of CryoCor™ Cryoablation for PAF

NCT00231296 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 174

Last updated 2017-05-04

No results posted yet for this study

Summary

A multi-center, randomized, controlled study of cryoablation vs medical management for the treatment of PAF

Conditions

Interventions

DEVICE

Cardiac CryoCor Cryoablation System

Treatment with CryoCor Cardiac Cryoablation system

DRUG

Medical management

Medical management- treatment with standard medical therapy, which includes anti-arrhythmic medications

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Gregory Feld, MD · University of California, San Diego

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-11-30
Primary Completion
2009-03-31
Completion
2009-03-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00231296 on ClinicalTrials.gov